Multiple sclerosis risk sharing scheme: a costly failure
Data Sharing
DOI:
10.1136/bmj.c1672
Publication Date:
2010-06-04T02:51:25Z
AUTHORS (1)
ABSTRACT
The NHS is paying for thousands of patients with multiple sclerosis to receive drugs that monitoring data suggest are not effective. <b>James Raftery</b> examines what went wrong the access scheme facilitated their use
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (57)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....